Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The Linacre Quarterly
|
August 8, 2018
Ethical Dilemnia of the Therapeutic Decisions in the Care of the Severe Chronic Anorexia Nervosa: About a Case
V Scolan, O Praline, N Carlin, et al.
Presse Medicale (Paris, France : 1983)
|
March 1, 2003
[Patients hospitalized in advanced or terminal phase of a serious life-threatening disease]
M-L Villard, N Carlin, G Laval, et al.
Journal of Virology
|
November 1, 1979
Salmonella bacteriophage glycanases: endorhamnosidases of Salmonella typhimurium bacteriophages
S B Svenson, J Lönngren, N Carlin, et al.
Vaccine
|
June 3, 2008
Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin
A Boberg, S Gaunitz, A Bråve, et al.
Carbohydrate Research
|
February 1, 1989
Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity
M Andersson, N Carlin, K Leontein, et al.
Journal of Health Communication
|
May 3, 2012
The use of mobile phones for acute wound care: attitudes and opinions of emergency department patients
Neal Sikka, Katrina N Carlin, Jesse Pines, et al.
The American Surgeon
|
August 25, 2020
The 11-Item Modified Frailty Index as a Tool to Predict Unplanned Events in Traumatic Brain Injury
Brett M Tracy, Margo N Carlin, James W Tyson, et al.
Joint Commission Journal on Quality and Patient Safety
|
November 23, 2023
The TeamSTEPPS for Improving Diagnosis Team Assessment Tool: Scale Development and Psychometric Evaluation
Kisha J Ali, Christine A Goeschel, Melissa M Eckroade, et al.
Vaccine
|
April 2, 2013
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant
J Holmgren, L Bourgeois, N Carlin, et al.
Vaccine
|
January 12, 2013
Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein
A Lundgren, S Leach, J Tobias, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The Linacre Quarterly
|
August 8, 2018
Ethical Dilemnia of the Therapeutic Decisions in the Care of the Severe Chronic Anorexia Nervosa: About a Case
V Scolan, O Praline, N Carlin, et al.
Presse Medicale (Paris, France : 1983)
|
March 1, 2003
[Patients hospitalized in advanced or terminal phase of a serious life-threatening disease]
M-L Villard, N Carlin, G Laval, et al.
Journal of Virology
|
November 1, 1979
Salmonella bacteriophage glycanases: endorhamnosidases of Salmonella typhimurium bacteriophages
S B Svenson, J Lönngren, N Carlin, et al.
Vaccine
|
June 3, 2008
Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin
A Boberg, S Gaunitz, A Bråve, et al.
Carbohydrate Research
|
February 1, 1989
Structural studies of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity
M Andersson, N Carlin, K Leontein, et al.
Journal of Health Communication
|
May 3, 2012
The use of mobile phones for acute wound care: attitudes and opinions of emergency department patients
Neal Sikka, Katrina N Carlin, Jesse Pines, et al.
The American Surgeon
|
August 25, 2020
The 11-Item Modified Frailty Index as a Tool to Predict Unplanned Events in Traumatic Brain Injury
Brett M Tracy, Margo N Carlin, James W Tyson, et al.
Joint Commission Journal on Quality and Patient Safety
|
November 23, 2023
The TeamSTEPPS for Improving Diagnosis Team Assessment Tool: Scale Development and Psychometric Evaluation
Kisha J Ali, Christine A Goeschel, Melissa M Eckroade, et al.
Vaccine
|
April 2, 2013
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant
J Holmgren, L Bourgeois, N Carlin, et al.
Vaccine
|
January 12, 2013
Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein
A Lundgren, S Leach, J Tobias, et al.
Page
of 3